Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jeffrey

Showing results (471-480 of 744) with videos related to

Pageof 75
Sort By:
The Journal of Urology|November 29, 2022
Intraoperative Blood Transfusion Is Associated With Increased Risk of Venous Thromboembolism After Radical CystectomyAmanda Myers, Igor Frank, Paras H Shah, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 7, 2009
Uric acid levels and outcome from coronary artery bypass graftingGraham S Hillis, Brian H Cuthbertson, Patrick H Gibson, et al.
European Urology|November 10, 2018
Which Patients with Clinically Node-positive Prostate Cancer Should Be Considered for Radical Prostatectomy as Part of Multimodal Treatment? The Impact of Nodal Burden on Long-term OutcomesGiorgio Gandaglia, Matteo Soligo, Antonino Battaglia, et al.
American Heart Journal|October 31, 2007
Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass graftingPatrick H Gibson, Bernard L Croal, Brian H Cuthbertson, et al.
Clinical Genitourinary Cancer|August 19, 2017
Adverse Pathology After Neoadjuvant Chemotherapy and Radical Cystectomy: The Role of Adjuvant ChemotherapyWilliam P Parker, Elizabeth B Habermann, Courtney N Day, et al.
Clinical Genitourinary Cancer|September 8, 2020
Development and Validation of a Novel TP53 Mutation Signature That Predicts Risk of Metastasis in Primary Prostate CancerFallon E Chipidza, Mohammed Alshalalfa, Brandon A Mahal, et al.
European Urology Oncology|August 15, 2019
There Is No Way to Avoid Systematic Prostate Biopsies in Addition to Multiparametric Magnetic Resonance Imaging Targeted BiopsiesPaolo Dell'Oglio, Armando Stabile, Matteo Soligo, et al.
The Journal of Urology|January 12, 2005
Monitoring intravesical therapy for superficial bladder cancer using fluorescence in situ hybridizationBenjamin R Kipp, R Jeffrey Karnes, Shannon M Brankley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapyRobert B Den, Kasra Yousefi, Edouard J Trabulsi, et al.
Environment International|April 5, 2016
Guidance on assessing the methodological and reporting quality of toxicologically relevant studies: A scoping reviewGbeminiyi O Samuel, Sebastian Hoffmann, Robert A Wright, et al.
Pageof 75

Showing results (471-480 of 744) with videos related to

Sort By:
Pageof 75
The Journal of Urology|November 29, 2022
Intraoperative Blood Transfusion Is Associated With Increased Risk of Venous Thromboembolism After Radical CystectomyAmanda Myers, Igor Frank, Paras H Shah, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 7, 2009
Uric acid levels and outcome from coronary artery bypass graftingGraham S Hillis, Brian H Cuthbertson, Patrick H Gibson, et al.
European Urology|November 10, 2018
Which Patients with Clinically Node-positive Prostate Cancer Should Be Considered for Radical Prostatectomy as Part of Multimodal Treatment? The Impact of Nodal Burden on Long-term OutcomesGiorgio Gandaglia, Matteo Soligo, Antonino Battaglia, et al.
American Heart Journal|October 31, 2007
Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass graftingPatrick H Gibson, Bernard L Croal, Brian H Cuthbertson, et al.
Clinical Genitourinary Cancer|August 19, 2017
Adverse Pathology After Neoadjuvant Chemotherapy and Radical Cystectomy: The Role of Adjuvant ChemotherapyWilliam P Parker, Elizabeth B Habermann, Courtney N Day, et al.
Clinical Genitourinary Cancer|September 8, 2020
Development and Validation of a Novel TP53 Mutation Signature That Predicts Risk of Metastasis in Primary Prostate CancerFallon E Chipidza, Mohammed Alshalalfa, Brandon A Mahal, et al.
European Urology Oncology|August 15, 2019
There Is No Way to Avoid Systematic Prostate Biopsies in Addition to Multiparametric Magnetic Resonance Imaging Targeted BiopsiesPaolo Dell'Oglio, Armando Stabile, Matteo Soligo, et al.
The Journal of Urology|January 12, 2005
Monitoring intravesical therapy for superficial bladder cancer using fluorescence in situ hybridizationBenjamin R Kipp, R Jeffrey Karnes, Shannon M Brankley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapyRobert B Den, Kasra Yousefi, Edouard J Trabulsi, et al.
Environment International|April 5, 2016
Guidance on assessing the methodological and reporting quality of toxicologically relevant studies: A scoping reviewGbeminiyi O Samuel, Sebastian Hoffmann, Robert A Wright, et al.
Pageof 75